H47.23 Glaucomatous optic atrophy

Name of the Condition

• Glaucomatous Optic Atrophy

Summary

Glaucomatous optic atrophy is a condition characterized by the degeneration of the optic nerve due to glaucoma, leading to the loss of retinal ganglion cells and impaired visual function. This damage results in reduced visual acuity, color vision deficits, and visual field abnormalities. The condition is typically progressive, with severity depending on the extent of nerve damage and intraocular pressure control.

Causes

The primary cause of glaucomatous optic atrophy is elevated intraocular pressure, which damages the optic nerve over time. Other contributing factors may include chronic angle-closure glaucoma, normal-tension glaucoma, or secondary glaucoma from underlying eye conditions or systemic diseases.

Risk Factors

Risk factors include advanced age, family history of glaucoma, elevated intraocular pressure, African or Hispanic ancestry, thin corneas, and certain medical conditions such as diabetes or hypertension. Long-term use of corticosteroids may also increase susceptibility.

Symptoms

Symptoms typically include progressive vision loss, reduced peripheral vision (tunnel vision), difficulty with contrast sensitivity, and color vision deficits. Some patients may experience eye pain or headaches, though these are less common.

Diagnosis

Diagnosis involves a comprehensive eye examination, including visual acuity testing, intraocular pressure measurement, optic nerve imaging (e.g., OCT), and visual field testing. Gonioscopy may be performed to assess the eye's drainage angle, and pachymetry to measure corneal thickness.

Treatment Options

Treatment focuses on lowering intraocular pressure through medications (e.g., prostaglandin analogs, beta-blockers), laser therapy (e.g., trabeculoplasty), or surgery (e.g., trabeculectomy, tube shunt implantation). Regular monitoring is essential to adjust treatment and prevent further damage.

Prognosis and Follow-Up

Prognosis depends on early detection and effective intraocular pressure control. With proper management, progression can be slowed, but existing damage is often irreversible. Follow-up visits typically occur every 3–6 months, with more frequent monitoring during treatment adjustments.

Complications

Complications may include permanent vision loss, blindness, and reduced quality of life due to visual impairment. Untreated or poorly controlled glaucoma can lead to irreversible optic nerve damage and severe visual field loss.

Lifestyle & Prevention

Lifestyle modifications include regular eye exams, adherence to prescribed medications, and avoiding activities that increase intraocular pressure (e.g., heavy lifting). Smoking cessation and a balanced diet may also support overall eye health.

When to Seek Professional Help

Seek immediate care for sudden vision loss, severe eye pain, nausea, or halos around lights, as these may indicate acute angle-closure glaucoma. Regular follow-ups are recommended for those with glaucoma or risk factors.

Tips for Medical Coders

Document the underlying glaucoma type and any contributing factors to support the diagnosis. Ensure clinical notes specify the relationship between glaucoma and optic atrophy, as this is critical for accurate coding. Verify that the code aligns with the documented clinical findings and progression of the condition.